Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1992 Nov;157(5):534–538.

Effects of the multiple risk factor intervention trial smoking cessation program on pulmonary function. A randomized controlled trial.

W S Browner 1, A G Du Chene 1, S B Hulley 1
PMCID: PMC1022032  PMID: 1441495

Abstract

To determine whether the decline in pulmonary function in smokers is modified by stop-smoking intervention, a randomized controlled study (the Multiple Risk Factor Intervention Trial) was done comparing participants in a special intervention group that included an intensive smoking cessation program with those assigned to usual care. The subjects were 6,347 middle-aged male smokers who had serial measurements of pulmonary function--principally the forced expiratory volume in 1 second (FEV1)--during 6 to 7 years of follow-up. No overall differences were detected in the rate of loss of FEV1 in the two groups. The use of beta-blockers, which had detrimental effects on FEV1, was significantly more common in the intervention group. Among nonusers of beta-blockers, heavy smokers lost FEV1 at a rate about 11 ml per year slower in the intervention group than in the control group (2P = .09) and ended the trial with an FEV1 about 90 ml higher (2P = .05). These results support the inference from observational studies that smoking cessation has a beneficial effect on pulmonary function in heavy smokers.

Full text

PDF
537

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley F., Kannel W. B., Sorlie P. D., Masson R. Pulmonary function: relation to aging, cigarette habit, and mortality. Ann Intern Med. 1975 Jun;82(6):739–745. doi: 10.7326/0003-4819-82-6-739. [DOI] [PubMed] [Google Scholar]
  2. Beck G. J., Doyle C. A., Schachter E. N. Smoking and lung function. Am Rev Respir Dis. 1981 Feb;123(2):149–155. doi: 10.1164/arrd.1981.123.2.149. [DOI] [PubMed] [Google Scholar]
  3. Bossé R., Sparrow D., Rose C. L., Weiss S. T. Longitudinal effect of age and smoking cessation on pulmonary function. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):378–381. doi: 10.1164/arrd.1981.123.4.378. [DOI] [PubMed] [Google Scholar]
  4. Browner W. S., Newman T. B. Are all significant P values created equal? The analogy between diagnostic tests and clinical research. JAMA. 1987 May 8;257(18):2459–2463. [PubMed] [Google Scholar]
  5. Buist A. S., Sexton G. J., Nagy J. M., Ross B. B. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis. 1976 Jul;114(1):115–122. doi: 10.1164/arrd.1976.114.1.115. [DOI] [PubMed] [Google Scholar]
  6. Camilli A. E., Burrows B., Knudson R. J., Lyle S. K., Lebowitz M. D. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis. 1987 Apr;135(4):794–799. doi: 10.1164/arrd.1987.135.4.794. [DOI] [PubMed] [Google Scholar]
  7. Hughes G. H., Hymowitz N., Ockene J. K., Simon N., Vogt T. M. The multiple risk factor intervention trial (MRFIT). V. Intervention on smoking. Prev Med. 1981 Jul;10(4):476–500. doi: 10.1016/0091-7435(81)90061-x. [DOI] [PubMed] [Google Scholar]
  8. Hughes J. A., Hutchison D. C., Bellamy D., Dowd D. E., Ryan K. C., Hugh-Jones P. The influence of cigarette smoking and its withdrawal on the annual change of lung function in pulmonary emphysema. Q J Med. 1982 Spring;51(202):115–124. [PubMed] [Google Scholar]
  9. Kumana C. R., Kaye C. M., Leighton M., Turner P., Hamer J. Cardiac and pulmonary effects of acebutolol. Lancet. 1975 Jul 19;2(7925):89–93. doi: 10.1016/s0140-6736(75)90001-x. [DOI] [PubMed] [Google Scholar]
  10. Macdonald A. G., Ingram C. G., McNeill R. S. The effect of propranolol on airway resistance. Br J Anaesth. 1967 Dec;39(12):919–926. doi: 10.1093/bja/39.12.919. [DOI] [PubMed] [Google Scholar]
  11. McCarthy D. S., Craig D. B., Cherniack R. M. Effect of modification of the smoking habit on lung function. Am Rev Respir Dis. 1976 Jul;114(1):103–113. doi: 10.1164/arrd.1976.114.1.103. [DOI] [PubMed] [Google Scholar]
  12. McNeill R. S., Ingram C. G. Effect of propranolol on ventilatory function. Am J Cardiol. 1966 Sep;18(3):473–475. doi: 10.1016/0002-9149(66)90072-5. [DOI] [PubMed] [Google Scholar]
  13. Nemery B., Moavero N. E., Brasseur L., Stănescu D. C. Changes in lung function after smoking cessation: an assessment from a cross-sectional survey. Am Rev Respir Dis. 1982 Jan;125(1):122–124. doi: 10.1164/arrd.1982.125.1.122. [DOI] [PubMed] [Google Scholar]
  14. Rice D. P., Hodgson T. A., Sinsheimer P., Browner W., Kopstein A. N. The economic costs of the health effects of smoking, 1984. Milbank Q. 1986;64(4):489–547. [PubMed] [Google Scholar]
  15. Rose G., Hamilton P. J. A randomised controlled trial of the effect on middle-aged men of advice to stop smoking. J Epidemiol Community Health. 1978 Dec;32(4):275–281. doi: 10.1136/jech.32.4.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tager I. B., Segal M. R., Speizer F. E., Weiss S. T. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis. 1988 Oct;138(4):837–849. doi: 10.1164/ajrccm/138.4.837. [DOI] [PubMed] [Google Scholar]
  17. Tashkin D. P., Clark V. A., Coulson A. H., Simmons M., Bourque L. B., Reems C., Detels R., Sayre J. W., Rokaw S. N. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population. Am Rev Respir Dis. 1984 Nov;130(5):707–715. doi: 10.1164/arrd.1984.130.5.707. [DOI] [PubMed] [Google Scholar]
  18. Tockman M., Menkes H., Cohen B., Permutt S., Benjamin J., Ball W. C., Jr, Tonascia J. A comparison of pulmonary function in male smokers and nonsmokers. Am Rev Respir Dis. 1976 Oct;114(4):711–722. doi: 10.1164/arrd.1976.114.4.711. [DOI] [PubMed] [Google Scholar]
  19. Townsend M. C., DuChene A. G., Morgan J., Browner W. S. Pulmonary function in relation to cigarette smoking and smoking cessation. MRFIT Research Group. Prev Med. 1991 Sep;20(5):621–637. doi: 10.1016/0091-7435(91)90059-d. [DOI] [PubMed] [Google Scholar]
  20. Townsend M. C., Morgan J., Durkin D., DuChene A. G., Lamb S. Quality control aspects of pulmonary function testing in the Multiple Risk Factor Intervention Trial. Control Clin Trials. 1986 Sep;7(3 Suppl):179S–192S. doi: 10.1016/0197-2456(86)90167-4. [DOI] [PubMed] [Google Scholar]
  21. Vogt T. M., Selvin S., Widdowson G., Hulley S. B. Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am J Public Health. 1977 Jun;67(6):545–549. doi: 10.2105/ajph.67.6.545. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES